Upcoming Webinars 2024

26th Nov

7pm to
9pm

Navigating Menopause: A comprehensive overview with Nurse Consultant Nikki Noble.

  • Introduction to menopause and its impact on genitourinary health.
  • Identification and assessment of genitourinary symptoms.
  • Overview of the medical management landscape.
  • Q&A session.

Blissel® offers women with vaginal atrophy a different treatment experience

Blissel® is the first and only prescribable estriol containing gel for the treatment of vaginal atrophy.1,2

Blissel® is the first and only prescribable estriol containing gel for the treatment of vaginal atrophy.1,2

My Blissel Time to talk
Video Library

A library of discussions led by national experts Dr Anne Connolly, Dr Diana Mansour and Nurse Specialist Consultant Nikki Noble.
The videos cover a range of very useful, relevant and important topics, including How Blissel® works, the time until Blissel® takes effect, and how to use an applicator.

The Blissel® formulation may have multiple beneficial effects

Blissel® uses polycarbophilic components to form a mucoadhesive gel, which leads to a moisturising effect whilst also increasing retention of the active hormone ingredient.3

Products which are not mucoadhesive may be in contact with the vaginal tissues for a shorter time and may lead to leakage.3

The British Menopause Society suggests that patients should be given the lowest HRT dose that will effectively manage their bothersome symptoms.4

Low dose estriol formulations, such as Blissel®, have a lower systemic absorption than medications which contain a higher hormonal dose.5

With Blissel®, women do not have a long wait for relief

Blissel® can give your patients a rapid improvement in their symptoms from the first days of treatment.3

Prescribe Blissel® by brand for your patients. Blissel® is the first and only prescribable estriol containing gel for the treatment of vaginal atrophy.1,2

How Blissel
Works

Efficacy

Dosing

Ultra low dose estriol vaginal gel1,2

Prescribing and Adverse event reporting information for Blissel can be found here.

 Adverse events should be reported. Reporting forms and information can be found at yellowcard.mhra.gov.uk or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to Consilient Health (UK) Ltd, No. 1 Church Road, Richmond upon Thames, Surrey TW9 2QE UK or drugsafety@consilienthealth.com 

  1. Blissel 50 micrograms/g vaginal gel. Summary of product characteristics.
  2. Cano A, et al. Menopause. 2012;19(10):1130-9.
  3. Lázaro-Carrasco de la Fuente J, et al. J Menopausal Med. 2022;28(2):60-69.
  4. British Menopause Society Women’s Health Concern Fact Sheet: HRT Benefits and Risks; Nov 2022.
  5. Delgado JL, et al. Climacteric. 2016;19(2):172-80.

Date of preparation: Oct 2024 | UK-BLS-585